Variables Influencing Tumor Dosimetry in Radioimmunotherapy of CEA-Expressing Cancers with Anti-CEA and Antimucin Monoclonal Antibodies

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.